1. Home
  2. SGHC vs CNTA Comparison

SGHC vs CNTA Comparison

Compare SGHC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SGHC

Super Group (SGHC) Limited

HOLD

Current Price

$13.52

Market Cap

6.6B

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$39.75

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHC
CNTA
Founded
2020
2020
Country
Guernsey
United Kingdom
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.1B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SGHC
CNTA
Price
$13.52
$39.75
Analyst Decision
Strong Buy
Buy
Analyst Count
6
9
Target Price
$17.33
$43.17
AVG Volume (30 Days)
3.7M
1.3M
Earning Date
05-11-2026
05-13-2026
Dividend Yield
3.52%
N/A
EPS Growth
N/A
29.13
EPS
N/A
N/A
Revenue
N/A
$15,000,000.00
Revenue This Year
$16.09
N/A
Revenue Next Year
$9.73
N/A
P/E Ratio
$20.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.46
$10.95
52 Week High
$14.38
$40.26

Technical Indicators

Market Signals
Indicator
SGHC
CNTA
Relative Strength Index (RSI) 63.14 72.07
Support Level $10.18 $39.36
Resistance Level $14.23 $39.86
Average True Range (ATR) 0.58 0.12
MACD -0.02 -0.24
Stochastic Oscillator 64.11 67.65

Price Performance

Historical Comparison
SGHC
CNTA

About SGHC Super Group (SGHC) Limited

Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's four operating segments-Betway, Spin, Jumpman and DGC. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.

Share on Social Networks: